Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

<p><strong>Background</strong> As trials of 5 years of tamoxifen in early breast cancer mature, the relevance of hormone receptor measurements (and other patient characteristics) to long-term outcome can be assessed increasingly reliably. We report updated meta-analyses of the tria...

תיאור מלא

מידע ביבליוגרפי
מחבר ראשי: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
מחברים אחרים: Davies, C
פורמט: Journal article
שפה:English
יצא לאור: Elsevier 2011